CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-18 | Worthington Mark General Counsel | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-01-18 | MOEBIUS HANS Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2022-01-18 | CHURCH KEVIN Executive VP, Research | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-04 | MILESON GLENNA Chief Financial Officer | Exercise or conversion | +6,305 | $1.35 | $9K | 97,060 |
| 2022-01-04 | MILESON GLENNA Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,305 | 0 | ||
| 2021-11-18 | Litton Mark James Chief Executive Officer | Grant or award | +885 | $12.51 | $11K | 115,758 |
| 2021-11-18 | MOEBIUS HANS Chief Medical Officer | Grant or award | +829 | $12.51 | $10K | 31,256 |
| 2021-11-18 | CHURCH KEVIN Executive VP, Research | Grant or award | +96 | $12.51 | $1K | 44,414 |
| 2021-11-18 | MILESON GLENNA Chief Financial Officer | Grant or award | +931 | $12.51 | $12K | 90,755 |
| 2021-11-03 | Worthington Mark General Counsel | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-11-03 | Lenington Rachel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-08-17 | Litton Mark James Chief Operating Officer | Exercise or conversion | +50,440 | $1.35 | $68K | 114,873 |
| 2021-08-17 | Litton Mark James Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) | −50,440 | 100,880 | ||
| 2021-07-21 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion | +12,610 | $1.35 | $17K | 14,665 |
| 2021-07-21 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion | +15,762 | $1.35 | $21K | 30,427 |
| 2021-07-21 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −12,610 | 0 | ||
| 2021-07-21 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −15,762 | 15,763 | ||
| 2021-06-15 | FLUKE JOHN M JR Director | Other disposition | −3,000 | 3,731 | ||
| 2021-06-15 | FLUKE JOHN M JR Director | Other acquisition | +1,000 | 144,884 | ||
| 2021-06-10 | MILESON GLENNA Chief Financial Officer | Exercise or conversion | +6,305 | $1.35 | $9K | 89,824 |
Page 15 of 18 · 349 trades